Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other financing activities (2019 - 2025)

Historic Other financing activities for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to $72000.0.

  • Benitec Biopharma's Other financing activities fell 9754.1% to $72000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year decrease of 6064.15%. This contributed to the annual value of $2.3 million for FY2025, which is 6064.15% down from last year.
  • According to the latest figures from Q2 2025, Benitec Biopharma's Other financing activities is $72000.0, which was down 9754.1% from $2.2 million recorded in Q1 2025.
  • Benitec Biopharma's 5-year Other financing activities high stood at $3.0 million for Q3 2023, and its period low was $2000.0 during Q4 2024.
  • For the 5-year period, Benitec Biopharma's Other financing activities averaged around $1.7 million, with its median value being $1.9 million (2022).
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 5858.75% in 2023, then plummeted by 9754.1% in 2025.
  • Quarter analysis of 5 years shows Benitec Biopharma's Other financing activities stood at $1.6 million in 2021, then grew by 17.92% to $1.9 million in 2022, then skyrocketed by 58.59% to $3.0 million in 2023, then crashed by 99.93% to $2000.0 in 2024, then skyrocketed by 3500.0% to $72000.0 in 2025.
  • Its Other financing activities stands at $72000.0 for Q2 2025, versus $2.2 million for Q1 2025 and $2000.0 for Q4 2024.